Search
Search Constraints
You searched for: Author/Creator Malikowska-Racia, NataliaLimit your search
- Malikowska-Racia, Natalia [remove] 2
- 615.105 1
- 615.78 1
- AEA anandamide -- ACTH adrenocorticotropic factor -- AH anterior hippocampus -- AlloP allopregnanolone -- AMPA α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid -- AVP arginine vasopressin/vasopressin -- BEP Brief Eclectic Psychotherapy -- BDNF brain-derived neurotrophic factor -- BK channels large-conductance potassium channels -- BLA basolateral amygdala -- BST bed nucleus of the stria terminalis -- CB1R cannabinoid receptor type 1 -- CeMA medial subdivision of central amygdala -- CPT cognitive processing therapy -- CRH corticotropin-releasing factor -- CRH1R corticotropin-releasing hormone receptor 1 -- CRH2R corticotropin-releasing hormone receptor 2 -- CRHRs corticotropin-releasing hormone receptors -- CS conditioned stimulus -- CSF cerebrospinal fluid -- D1–5R dopaminergic receptors types 1–5 -- DHEA dehydroepiandrosterone -- EMDR Eye Movement Desensitization and Reprocessing -- ErbB4 receptor receptor tyrosine-protein kinase erbB-4 -- FAAH fatty acid amide hydrolase -- GABAAR GABA receptor type A -- GABABR GABA receptor type B -- GAD glutamate decarboxylase -- GR glucocorticoid receptor -- HPA hypothalamic–pituitary–adrenal axis -- HPT hypothalamic–pituitary–thyroid axis -- LC locus coeruleus -- LTD long-term depression -- LTP long-term potentiation -- mGluR1 metabotropic glutamate receptor type 1 -- mGluR2/3 metabotropic glutamate receptors types 2 and 3 -- mGluR5 metabotropic glutamate receptor type 5 -- mPFC medial prefrontal cortex -- mPR membrane progesterone receptor -- MR mineralocorticoid receptors -- NE norepinephrine -- NET narrative exposure therapy -- NET norepinephrine transporter -- NMDAR N-methyl-d-aspartate receptor -- NOS nitrogen monoxide synthase -- NRG-1 neuregulin 1 -- NY neuropeptide Y -- OT oxytocin -- OX1R orexin receptor type 1 -- PAG periaqueductal gray -- PE prolonged exposure -- PFC prefrontal cortex -- PRL prolactin -- PTSD posttraumatic stress disorder -- PVN paraventricular nucleus -- SBSSs selective brain steroidogenic stimulants -- SK channels small-conductance potassium channels -- SN substantia nigra -- SNP single nucleotide polymorphism -- SPS single prolonged stress protocol -- SRC-1 steroid receptor co-activator -- SSRIs selective serotonin reuptake inhibitors -- T3 triiodothyronine -- T4 thyroxine -- TSH thyroid-stimulating hormone -- US unconditioned stimulus -- VA U.S. Department of Veteran Affairs -- VH ventral hippocampus -- vmPFC ventromedial prefrontal cortex -- VOD U.S. Department of Defense -- VTA ventral tegmental area -- Y2R neuropeptide Y2 receptor 1
- Autonomic Agents -- Periodicals 1
- Bromocriptine mesylate (PubChem CID -- 31100) -- Modafinil (PubChem CID -- 4236) -- Dihydrexidine hydrochloride (PubChem CID -- 11957519) -- Rotigotine hydrochloride (PubChem CID -- 180335) -- Pramipexole dihydrochloride (PubChem CID -- 119569) 1
- Electronic journals 1
- FC fear conditioning -- EPM elevated plus maze test -- FST forced swim test -- SLA spontaneous locomotor activity -- mSPS mouse single prolonged stress -- SPS single prolonged stress -- USVs ultrasonic vocalizations 1
- Médicaments -- Recherche -- Périodiques 1
- Neuropsychopharmacologie -- Périodiques 1
- Neuropsychopharmacology 1